Literature DB >> 31643029

Antibacterial spectrum of human omentum and differential expression of beta defensins.

Meenu Srivastava1, Abhijit Chandra2, Jyotsna Agarwal3, Rahul Rahul1, Jaya Nigam1, Devendra Parmar4, Leena Khare Satyam5.   

Abstract

BACKGROUND: Human β defensins (hBD1 and hBD2) are cationic, cysteine-rich peptides and form an integral part of the mammalian innate immune system. hBD1 is constitutively expressed in epithelial cells, whereas hBD2 increases in response to bacterial infection. Human omentum is known for its anti-inflammatory properties and also possesses an antibacterial activity of its own. We hypothesized that antimicrobial peptides, β defensins, may govern host defense mechanism in the microbe-rich environment of the peritoneal cavity. Therefore, we analyzed the expression of hBD1 and hBD2 in omentum tissue in vivo and also studied the antibacterial activity of omentum against common pathogens.
METHODOLOGY: Omentum tissues were obtained from 30 patients (15 cases and 15 controls). Real-time polymerase chain reaction (PCR) was used to evaluate the mRNA expression of hBD1 and hBD2. Protein quantification was done using Western blotting technique. Antibacterial susceptibility was performed to check the antibacterial activity of omentum. RESULT: Significantly higher expression of hBD2 was observed in cases compared to controls at both the transcriptional and translational levels. In comparison with an array of antibiotics, activated omentum also showed antibacterial property even at lower concentration of its extract.
CONCLUSION: Omentum directly responds to bacterial infection, which may be due to differential expression of hBD1 and hBD2 in human omental tissue. These peptides (hBD1 and hBD2) may be an ideal candidate for novel antibiotic class with a broad-spectrum activity.

Entities:  

Keywords:  Antibacterial spectrum; Omentum; Real-time PCR; hBD1; hBD2

Year:  2019        PMID: 31643029     DOI: 10.1007/s12664-019-00981-4

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  33 in total

1.  The greater omentum as a site of antibody synthesis.

Authors:  F C WALKER; A W ROGERS
Journal:  Br J Exp Pathol       Date:  1961-06

2.  Inducible expression of an antibiotic peptide gene in lipopolysaccharide-challenged tracheal epithelial cells.

Authors:  G Diamond; J P Russell; C L Bevins
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

Review 3.  Antimicrobial peptides of vertebrates.

Authors:  T Ganz; R I Lehrer
Journal:  Curr Opin Immunol       Date:  1998-02       Impact factor: 7.486

4.  Human beta-defensin-1: an antimicrobial peptide of urogenital tissues.

Authors:  E V Valore; C H Park; A J Quayle; K R Wiles; P B McCray; T Ganz
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

Review 5.  Immunological Functions of the Omentum.

Authors:  Selene Meza-Perez; Troy D Randall
Journal:  Trends Immunol       Date:  2017-06-01       Impact factor: 16.687

6.  Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease.

Authors:  Jan Wehkamp; Klaus Fellermann; Klaus R Herrlinger; Steffi Baxmann; Klaus Schmidt; Bettina Schwind; Michael Duchrow; Charlotte Wohlschläger; Alfred C Feller; Eduard F Stange
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-07       Impact factor: 2.566

7.  Expression of the peptide antibiotic human beta-defensin 1 in cultured gingival epithelial cells and gingival tissue.

Authors:  S Krisanaprakornkit; A Weinberg; C N Perez; B A Dale
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis.

Authors:  A Fahlgren; S Hammarström; A Danielsson; M-L Hammarström
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

9.  Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes.

Authors:  Kazushige Midorikawa; Kazuhisa Ouhara; Hitoshi Komatsuzawa; Toshihisa Kawai; Sakuo Yamada; Tamaki Fujiwara; Kenshi Yamazaki; Koji Sayama; Martin A Taubman; Hidemi Kurihara; Koji Hashimoto; Motoyuki Sugai
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

Review 10.  Antimicrobial peptides and their potential application in inflammation and sepsis.

Authors:  Tobias Schuerholz; Klaus Brandenburg; Gernot Marx
Journal:  Crit Care       Date:  2012-12-12       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.